These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25706312)

  • 21. Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates.
    Gauvain G; Akolkar H; Chaffiol A; Arcizet F; Khoei MA; Desrosiers M; Jaillard C; Caplette R; Marre O; Bertin S; Fovet CM; Demilly J; Forster V; Brazhnikova E; Hantraye P; Pouget P; Douar A; Pruneau D; Chavas J; Sahel JA; Dalkara D; Duebel J; Benosman R; Picaud S
    Commun Biol; 2021 Jan; 4(1):125. PubMed ID: 33504896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A neuroprosthesis for restoring sight.
    Viola MV; Patrinos AA
    Acta Neurochir Suppl; 2007; 97(Pt 2):481-6. PubMed ID: 17691338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited retinal degenerations: therapeutic prospects.
    Delyfer MN; Léveillard T; Mohand-Saïd S; Hicks D; Picaud S; Sahel JA
    Biol Cell; 2004 May; 96(4):261-9. PubMed ID: 15145530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases.
    Yan B; Nirenberg S
    IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daylight vision repair by cell transplantation.
    Santos-Ferreira T; Postel K; Stutzki H; Kurth T; Zeck G; Ader M
    Stem Cells; 2015 Jan; 33(1):79-90. PubMed ID: 25183393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice.
    van Wyk M; Schneider S; Kleinlogel S
    Mol Vis; 2015; 21():811-27. PubMed ID: 26283863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal prostheses in degenerative retinal diseases.
    Lin TC; Chang HM; Hsu CC; Hung KH; Chen YT; Chen SY; Chen SJ
    J Chin Med Assoc; 2015 Sep; 78(9):501-5. PubMed ID: 26142056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal prosthetics, optogenetics, and chemical photoswitches.
    Marc R; Pfeiffer R; Jones B
    ACS Chem Neurosci; 2014 Oct; 5(10):895-901. PubMed ID: 25089879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell-based therapeutic applications in retinal degenerative diseases.
    Huang Y; Enzmann V; Ildstad ST
    Stem Cell Rev Rep; 2011 Jun; 7(2):434-45. PubMed ID: 20859770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness.
    Singh RK; Binette F; Seiler M; Petersen-Jones SM; Nasonkin IO
    J Ocul Pharmacol Ther; 2021 Apr; 37(3):147-156. PubMed ID: 33052761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The detrimental effects of progression of retinal degeneration in the visual cortex.
    Bhattacharyya A
    Front Cell Neurosci; 2022; 16():904175. PubMed ID: 35966197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of HCN1 enhances disease progression in mouse models of CNG channel-linked retinitis pigmentosa and achromatopsia.
    Schön C; Asteriti S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Herms J; Seeliger MW; Cangiano L; Biel M; Michalakis S
    Hum Mol Genet; 2016 Mar; 25(6):1165-75. PubMed ID: 26740549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin.
    Lin B; Koizumi A; Tanaka N; Panda S; Masland RH
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):16009-14. PubMed ID: 18836071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
    Barone I; Novelli E; Strettoi E
    Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optogenetic restoration of retinal ganglion cell activity in the living primate.
    McGregor JE; Godat T; Dhakal KR; Parkins K; Strazzeri JM; Bateman BA; Fischer WS; Williams DR; Merigan WH
    Nat Commun; 2020 Apr; 11(1):1703. PubMed ID: 32245977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.